Johannes Gutenberg-Universität Mainz
- 6131/39-0
Nestle, U.; Schimek-Jasch, T.; Kremp, S. et al.
Imaging-Guided Target Volume Reduction in Radiotherapy of Lung Cancer: The Prospective Randomized Multinational PET-Plan TrialJOURNAL OF THORACIC ONCOLOGY. Bd. 14. H. 10. 2019 S. S238-S238
Kruip, Gerhard
Imago Dei und TranshumanismusET Studies. Bd. 10. H. 2. Leuven: Peeters 2019 S. V - VIII
Cheng, A-L.; Qin, S.; Ikeda, M. et al.
IMbrave150: Efficacy and safety results from a ph III study evaluating atezolizumab (atezo) 1 bevacizumab (bev) vs sorafenib (Sor) as first treatment (tx) for patients (pts) with unresectable hepatocellular carcinoma (HCC)ANNALS OF ONCOLOGY. Bd. 30. 2019
Tedja, Milly S.; Haarman, Annechien E. G.; Meester-Smoor, Magda A. et al.
IMI - Myopia Genetics ReportINVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. Bd. 60. H. 3. 2019 S. M89-M105
Moos, Sonja; Mohebiany, Alma N.; Waisman, Ari et al.
Imiquimod-Induced Psoriasis in Mice Depends on the IL-17 Signaling of KeratinocytesJOURNAL OF INVESTIGATIVE DERMATOLOGY. Bd. 139. H. 5. 2019 S. 1110-1117
Valerio, Luca; Klok, Frederikus A.; Barco, Stefano
Immediate and late impact of reperfusion therapies in acute pulmonary embolismEUROPEAN HEART JOURNAL SUPPLEMENTS. Bd. 21. H. I. 2019 S. I1-I13
Noelken, Robert; Pausch, Tobias; Ly, Thu-My et al.
Immediate implant placement of 5.4 mm OsseoSpeedTM EV implants in molar extraction sites with autogenous defect augmentationIMPLANTOLOGIE. Bd. 27. H. 3. 2019 S. 251-262
Nabar, Nikita D.; Brandt, Maximilian P.; Thomas, Christian et al.
Immune check point inhibitors for metastatic urothelial carcinoma: current evidence-based approach for urology daily practiceMINERVA UROLOGICA E NEFROLOGICA. Bd. 71. H. 3. 2019 S. 205-216
Grivas, Petros; Monk, Bradley J.; Petrylak, Daniel et al.
Immune Checkpoint Inhibitors as Switch or Continuation Maintenance Therapy in Solid Tumors: Rationale and Current StateTARGETED ONCOLOGY. Bd. 14. H. 5. 2019 S. 505-525
Sommer, M. E. L.; Dalia, R. A.; Nogueira, A. V. B. et al.
Immune response mediated by Th1 / IL-17 / caspase-9 promotes evolution of periodontal diseaseARCHIVES OF ORAL BIOLOGY. Bd. 97. 2019 S. 77-84